15 November 2023

Herbert Smith Freehills appoints new Pharma Co-Head

Herbert Smith Freehills has appointed Chris Parker KC as Co-Head of the firm's Pharmaceuticals group.Chris is a partner specialising in international ...

1 November 2023

Herbert Smith Freehills advises Zydus Lifesciences Limited on acquisition of the UK based LiqMeds Group

Leading international law firm Herbert Smith Freehills has advised Zydus Pharmaceuticals UK Limited, a 100% subsidiary of Indian multinational ...

12 June 2023

Herbert Smith Freehills advises sole sponsor and overall coordinators on Cutia Therapeutics' Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人和整体协调人律师为科笛集团香港上市提供法律服务

Leading international law firm Herbert Smith Freehills has advised the sole sponsor and the overall coordinators on Cutia Therapeutics (02487.HK)'s ...

15 December 2022

Herbert Smith Freehills advises joint sponsors on 3D Medicines' Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人律师为思路迪香港上市提供法律服务

Leading international law firm Herbert Smith Freehills has advised CICC and CSCI as joint sponsors of 3D Medicines Inc. (01244.HK)’s mainboard listing ...

18 November 2022

Herbert Smith Freehills and Hiswara Bunjamin & Tandjung advise Silk Road Fund on investment in Indonesian pharmaceutical SOEs 史密夫斐尔及Hiswara Bunjamin & Tandjung为丝路基金投资印尼国有制药企业提供法律咨询

Leading international law firm Herbert Smith Freehills and its associate firm Hiswara Bunjamin & Tandjung have advised China's Silk Road Fund on a ...

1 September 2022

Herbert Smith Freehills advises sponsors on Biocytogen Pharmaceuticals' Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为百奥赛图香港上市提供法律服务

Leading international law firm Herbert Smith Freehills has advised Goldman Sachs and China International Capital Corporation as joint sponsors and ...

19 August 2022

Herbert Smith Freehills advises Sanofi on €300 million equity investment in Innovent 史密夫斐尔律师事务所就赛诺菲对信达生物3亿欧元股权投资提供法律服务

Leading international law firm Herbert Smith Freehills has advised innovative global healthcare company Sanofi on its €300 million strategic equity ...

23 February 2022

Herbert Smith Freehills advises sponsors and underwriters on Lepu Biopharma's Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为乐普生物香港上市提供法律服务

Leading international law firm Herbert Smith Freehills has advised CICC and Morgan Stanley as joint sponsors and the underwriters of biopharmaceutical ...

13 July 2021

Herbert Smith Freehills advises sponsors on Brii Biosciences’ HK$2.483 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为腾盛博药24.83亿港元IPO提供法律服务

Leading global law firm Herbert Smith Freehills has advised Morgan Stanley and UBS as joint sponsors of biopharmaceutical company Brii Biosciences ...

27 November 2020

Herbert Smith Freehills advises on Gland Pharma’s US$872 million India IPO / 史密夫斐尔律师事务所为Gland Pharma 8.72亿美元印度IPO提供法律服务

Leading global law firm Herbert Smith Freehills has advised the book running lead managers on the global offering and listing of Gland Pharma Limited ...

9 June 2020

Herbert Smith Freehills advises Achilles Vaccines in record seed financing for biotech sector

Herbert Smith Freehills has advised Achilles Vaccines, a biotech company focusing on the research and development of vaccines against malaria and other ...

27 May 2020

Calls for increased domestic pharmaceutical production not warranted, say Herbert Smith Freehills experts

Increased commentary about Australia’s perceived vulnerability to pharmaceutical shortages have led to recent calls for an overhaul of the country’s ...